| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.49B | 13.75B | 13.84B | 13.33B | 13.39B | 12.87B |
| Gross Profit | 2.70B | 2.76B | 2.75B | 2.54B | 2.60B | 2.44B |
| EBITDA | 661.00M | 661.00M | 756.00M | 540.00M | 587.00M | 401.00M |
| Net Income | 300.00M | 313.00M | 376.00M | 206.00M | 207.00M | 132.00M |
Balance Sheet | ||||||
| Total Assets | 12.02B | 13.00B | 12.45B | 13.36B | 12.10B | 11.76B |
| Cash, Cash Equivalents and Short-Term Investments | 666.00M | 877.00M | 512.00M | 534.00M | 504.00M | 576.00M |
| Total Debt | 1.56B | 1.42B | 1.53B | 2.24B | 2.22B | 1.88B |
| Total Liabilities | 6.23B | 6.50B | 6.58B | 7.81B | 7.13B | 7.02B |
| Stockholders Equity | 5.31B | 5.96B | 5.38B | 5.08B | 4.53B | 4.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 446.00M | 778.00M | 106.00M | -354.00M | 122.00M |
| Operating Cash Flow | 0.00 | 700.00M | 1.02B | 289.00M | -81.00M | 309.00M |
| Investing Cash Flow | 0.00 | -130.00M | -205.00M | -192.00M | -254.00M | -145.00M |
| Financing Cash Flow | 0.00 | -214.00M | -833.00M | -66.00M | 263.00M | -138.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥97.74B | 7.85 | 7.99% | 3.89% | -2.47% | 15.81% | |
71 Outperform | ¥69.26B | 3.34 | ― | 2.88% | 2.48% | 10.65% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | ¥21.98B | 6.54 | ― | 2.18% | 4.32% | 62.65% | |
64 Neutral | ¥2.59B | 8.85 | ― | 2.71% | -0.66% | -17.46% | |
62 Neutral | ¥44.52B | 3.72 | ― | 1.81% | 1.29% | 27.31% | |
61 Neutral | ¥81.49B | 19.64 | 9.07% | 3.61% | 2.90% | 13.95% |